This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD)

This study has been terminated.
(DSMB recommendation for slow enrollment)
Sponsor:
Information provided by (Responsible Party):
Ivor Douglas, Denver Health and Hospital Authority
ClinicalTrials.gov Identifier:
NCT01362205
First received: May 24, 2010
Last updated: April 14, 2017
Last verified: April 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: September 2017
  Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)